Sertraline Hydrochloride Tablet
Product Images NDC 43063-754

2 FDA label images from Pd-rx Pharmaceuticals, Inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Sertraline Hydrochloride (NDC 43063-754). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Pd-rx Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

43063754 Label (43063754)

43063754 Label (43063754)
Label for Sertraline Hydrochloride USP 100 mg oral tablets by PD-Rx Pharmaceuticals, Inc., Oklahoma City, OK. The label shows a quantity of 90 tablets with NDC 43063-754-90, lot number G19A78, expiration 07/2021. The label includes dosage instructions and a warning to keep out of reach of children.*
FDA Label Image

Chemical Structure (Sertraline Str)

Chemical Structure (Sertraline Str)
Chemical structure of Sertraline Hydrochloride, showing its molecular framework including benzene rings and chlorine substitutions, consistent with the active ingredient in the Sertraline Hydrochloride 100 mg oral tablet by PD-Rx Pharmaceuticals, Inc.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.